| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9334866 | Reproductive BioMedicine Online | 2005 | 4 Pages |
Abstract
Recombinant follicle stimulating hormone has been available now for almost 10 years and many couples have benefited from its use. Its clinical efficacy, purity and safety profile have been extensively documented in numerous publications. Because of growing public concerns on the safety of gonadotrophins extracted from human urine, the future will lie in the recombinant technology, which will also enable the design of more convenient tailor-made gonadotrophins.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Henk J Out,